182 related articles for article (PubMed ID: 24257497)
1. Sunitinib treatment for multiple brain metastases from jejunal gastrointestinal stromal tumor: case report.
Takeuchi H; Koike H; Fujita T; Tsujino H; Iwamoto Y
Neurol Med Chir (Tokyo); 2014; 54(8):664-9. PubMed ID: 24257497
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in therapy for gastrointestinal stromal tumors.
Maki RG
Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
[TBL] [Abstract][Full Text] [Related]
3. [A long-term control of gastrointestinal stromal tumor with sunitinib].
Uno F; Fujiwara Y; Fujiwara T
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1241-4. PubMed ID: 24047789
[TBL] [Abstract][Full Text] [Related]
4. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
Sjölund K; Andersson A; Nilsson E; Nilsson O; Ahlman H; Nilsson B
World J Surg; 2010 Sep; 34(9):2090-7. PubMed ID: 20512492
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib in the management of gastrointestinal stromal tumours (GISTs).
Hopkins TG; Marples M; Stark D
Eur J Surg Oncol; 2008 Aug; 34(8):844-850. PubMed ID: 18082353
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.
Ruka W; Rutkowski P; Szawłowski A; Nowecki Z; Debiec-Rychter M; Grzesiakowska U; Dziewirski W; Siedlecki JA; Michej W
Eur J Surg Oncol; 2009 Jan; 35(1):87-91. PubMed ID: 18289826
[TBL] [Abstract][Full Text] [Related]
7. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H
Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667
[TBL] [Abstract][Full Text] [Related]
8. Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?
Pantaleo MA; Di Battista M; Catena F; Astorino M; Saponara M; Di Scioscio V; Santini D; Piazzi G; Castellucci P; Brandi G; Biasco G
J Cancer Res Clin Oncol; 2008 May; 134(5):625-30. PubMed ID: 18202855
[TBL] [Abstract][Full Text] [Related]
9. Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.
Demetri GD; Heinrich MC; Fletcher JA; Fletcher CD; Van den Abbeele AD; Corless CL; Antonescu CR; George S; Morgan JA; Chen MH; Bello CL; Huang X; Cohen DP; Baum CM; Maki RG
Clin Cancer Res; 2009 Sep; 15(18):5902-9. PubMed ID: 19737946
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors: imatinib and beyond.
Schnadig ID; Blanke CD
Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
[TBL] [Abstract][Full Text] [Related]
11. New paradigms in gastrointestinal stromal tumour management.
Blay JY
Ann Oncol; 2009 May; 20 Suppl 1():i18-24. PubMed ID: 19430004
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches to imatinib- and sunitinib-resistant GIST.
Reichardt P
Curr Oncol Rep; 2008 Jul; 10(4):344-9. PubMed ID: 18778561
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinib.
Svetlichnaya J; Huyck TK; Wayne JD; Agulnik M
Chemotherapy; 2012; 58(1):30-3. PubMed ID: 22415035
[TBL] [Abstract][Full Text] [Related]
14. [A case of imatinib-resistant GIST treated by sunitinib].
Sakamoto Y; Akimoto H; Kojo M; Kawano H; Chinen Y; Morita K; Sugiyama M; Saeki H; Minami K; Soejima Y; Sakaguchi Y; Toh Y; Okamura T
Gan To Kagaku Ryoho; 2011 May; 38(5):827-30. PubMed ID: 21566447
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
Nishida T; Omori T; Ueshima S
Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD; Reichardt P; Kang YK; Blay JY; Rutkowski P; Gelderblom H; Hohenberger P; Leahy M; von Mehren M; Joensuu H; Badalamenti G; Blackstein M; Le Cesne A; Schöffski P; Maki RG; Bauer S; Nguyen BB; Xu J; Nishida T; Chung J; Kappeler C; Kuss I; Laurent D; Casali PG;
Lancet; 2013 Jan; 381(9863):295-302. PubMed ID: 23177515
[TBL] [Abstract][Full Text] [Related]
17. Preoperative therapy with sunitinib malate in a patient with a gastrointestinal stromal tumor and liver metastases: A case report.
Wang ZQ; Wen ZQ; Yang J; Zhang HB; Kou ZY; Zhou RZ; Li WL
Medicine (Baltimore); 2019 Dec; 98(51):e14222. PubMed ID: 31860943
[TBL] [Abstract][Full Text] [Related]
18. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
19. Developments in targeted therapy of advanced gastrointestinal stromal tumors.
Rutkowski P; Symonides M; Zdzienicki M; Siedlecki JA
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):88-99. PubMed ID: 18537751
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports.
Schöffski P; Bukowski R; Flodgren P; Ravaud A
Ann Oncol; 2009 May; 20 Suppl 1():i25-i30. PubMed ID: 19430005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
